natgillin/translations-raw huggingface dataset:
The efficacy of Exelon transdermal patches in patients with Alzheimer's dementia has been demonstrated in a 24-week double-blind, placebo-controlled core study and its open-label extension phase and in a 48-week double-blind comparator study. 
Učinkovitost transdermalnih obližev Exelon pri bolnikih z Alzheimerjevo demenco so dokazali v 24-tedenski dvojno slepi, s placebom kontrolirani osnovni študiji in njenem odprtem podaljšku ter v 48-tedenski dvojno slepi primerjalni študiji.
If you have to undergo surgery whilst taking Exelon, tell your doctor before you are given any anaesthetics, because Exelon may exaggerate the effects of some muscle relaxants during anaesthesia. 
Če morate v času jemanja zdravila Exelon na operacijo, povejte zdravniku, da jemljete zdravilo Exelon, preden dobite kakršnokoli anestezijo, ker lahko zdravilo Exelon med anestezijo poveča učinke nekaterih mišičnih relaksantov.
When observed in patients treated with Exelon transdermal patches, skin irritation was mostly slight or mild in severity. 
Pri bolnikih, ki so se zdravili s transdermalnimi obliži Exelon, so večinoma opažali le rahlo ali blago izraženo vnetje.
Available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets. 
Na voljo so v pakiranju, ki vsebuje 7, 30 ali 42 vrečk, in v skupnem pakiranju, ki vsebuje 60, 84 ali 90 vrečk.
By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease. 
Zdravilo Exelon z zaviranjem navedenih encimov omogoča zvišanje koncentracije acetilholina v možganih in s tem pomaga pri zmanjševanju simptomov Alzheimerjeve bolezni in demence v povezavi s Parkinsonovo boleznijo.
• Paediatric population: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease. 
• Pediatrična populacija: Zdravilo Exelon ni namenjeno za uporabo pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
Particular caution must be exercised in titrating these patients (see sections 4.2 and 5.2). 
Pri titriranju odmerka tem bolnikom je potrebna posebna previdnost (glejte poglavji 4.2 in 5.2).
• The signs of Parkinson's disease get worse or getting similar signs - such as stiff muscles, difficulty in carrying out movements and muscle weakness 
• poslabšanje znakov Parkinsonove bolezni ali pojav podobnih znakov - na primer togih mišic ali težav pri izvajanju gibov in mišične šibkosti
EXP Use Exelon oral solution within 1 month of opening the bottle. 
EXP Peroralno raztopino Exelon porabite v 1 mesecu po prvem odprtju steklenice.
• Use Exelon oral solution within 1 month of opening the bottle. 
• Peroralno raztopino Exelon porabite v 1 mesecu po prvem odprtju steklenice.
Contact with the eyes should be avoided after handling Exelon transdermal patches (see section 5.3). 
Po rokovanju s transdermalnimi obliži Exelon se ne sme dotikati oči (glejte poglavje 5.3).
Rivastigmine was not mutagenic in a standard battery of in vitro and in vivo tests, except in a chromosomal aberration test in human peripheral lymphocytes at a dose exceeding 10 
V standardni bateriji testov in vitro in in vivo rivastigmin ni bil mutagen, razen v testu kromosomskih aberacij v človeških perifernih levkocitih v odmerku, ki je 10
If you forget to use Exelon 
Če ste pozabili uporabiti zdravilo Exelon
The following adverse reactions have only been observed with Exelon capsules and oral solution and not in clinical studies with Exelon transdermal patches: malaise, confusion, sweating increased (common); duodenal ulcers, angina pectoris (rare); gastrointestinal haemorrhage (very rare); and some cases of severe vomiting were associated with oesophageal rupture (not known). 
Naslednje neželene učinke so opažali samo pri uporabi kapsul in peroralne raztopine Exelon, ne pa v kliničnih študijah s transdermalnimi obliži Exelon: splošno slabo počutje, zmedenost, povečano potenje (pogosto); razjede dvanajstnika, angino pektoris (redko); krvavitev v prebavila (zelo redko); in nekaj primerov hudega bruhanja, ki je bilo povezano z rupturo požiralnika (pogostnost neznana).
The outer layer is beige and labelled with the following: - “Exelon”, “4.6 mg/24 h” and “AMCX”, - “Exelon”, “9.5 mg/24 h” and “BHDI”, - “Exelon”, “13.3 mg/24 h” and “CNFU”. 
Zunanja plast je rjavkasto bele barve z eno od naslednjih oznak: - “Exelon”, “4.6 mg/24 h” in “AMCX”, - “Exelon”, “9.5 mg/24 h” in “BHDI”, - “Exelon”, “13.3 mg/24 h” in “CNFU”.
Exelon 13.3 mg/24 h transdermal patches are available in packs containing 7 or 30 sachets and in multipacks containing 60 or 90 sachets. 
Zdravilo Exelon 13,3 mg/24 h transdermalni obliž je na voljo v pakiranju, ki vsebuje 7 ali 30 vrečk in v skupnem pakiranju, ki vsebuje 60 ali 90 vrečk.
Exelon 4.6 mg/24 h transdermal patches and Exelon 9.5 mg/24 h transdermal patches are available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets. 
Zdravili Exelon 4,6 mg/24 h transdermalni obliž in Exelon 9,5 mg/24 h transdermalni obliž sta na voljo v pakiranju, ki vsebuje 7, 30 ali 42 vrečk in v skupnem pakiranju, ki vsebuje 60, 84 ali 90 vrečk.
As rivastigmine has a plasma half-life of about 3.4 hours and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose all Exelon transdermal patches should be removed immediately and no further transdermal patch should be applied for the next 24 hours. 
Ker ima rivastigmin plazemski razpolovni čas okrog 3,4 ure in trajanje zaviranja acetilholinesteraze okrog 9 ur, v primeru asimptomatičnega prevelikega odmerka priporočamo takojšnjo odstranitev vseh transdermalnih obližev Exelon.
One of the inactive ingredients in Exelon oral solution is sodium benzoate. 
Ena od neaktivnih sestavin peroralne raztopine Exelon je natrijev benzoat.
What Exelon is and what it is used for What you need to know before you use Exelon How to use Exelon 
Kaj je zdravilo Exelon in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Exelon Kako uporabljati zdravilo Exelon Možni neželeni učinki
Patients with severe hepatic impairment have not been studied, however, Exelon capsules may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2). 
Uporabe zdravila pri bolnikih s težko jetrno okvaro niso proučili, bolniki iz te populacije lahko kljub temu uporabljajo zdravilo Exelon v obliki kapsul, vendar jih je treba skrbno spremljati (glejte poglavji 4.4 in 5.2).
If you forget to take Exelon 
Če ste pozabili vzeti zdravilo Exelon
Overdose with Exelon transdermal patch resulting from misuse/dosing errors (application of multiple patches at a time) has been reported in the post-marketing setting and rarely in clinical trials. 
V obdobju trženja zdravila so poročali o prevelikem odmerjanju s transdermalnimi obliži Exelon, do česar je prišlo zaradi nepravilne uporabe/odmerjanja (nameščenih več obližev hkrati), v kliničnih študijah pa so o takih primerih poročali le redko.
Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules 
Exelon 1,5 mg trde kapsule Exelon 3,0 mg trde kapsule Exelon 4,5 mg trde kapsule Exelon 6,0 mg trde kapsule
• Hepatic impairment: Due to increased exposure in mild to moderate hepatic impairment as observed with the oral formulation, dosing recommendations to titrate according to individual tolerability should be closely followed. 
Zaradi povečane izpostavljenosti zdravilu pri blagi do zmerni okvari jeter, kar so opažali pri uporabi peroralnih oblik zdravila, se je treba natančno ravnati po priporočilih, naj se odmerjanje titrira glede na individualno prenašanje.
If you are pregnant, the benefits of using Exelon must be assessed against the possible effects on your unborn child. Exelon should not be used during pregnancy unless clearly necessary. 
V primeru, da ste noseči, je treba pretehtati koristi uporabe zdravila Exelon in možne učinke na nerojenega otroka.
7 transdermal patches 30 transdermal patches 42 transdermal patches 
7 transdermalnih obližev 30 transdermalnih obližev 42 transdermalnih obližev
What you need to know before you use Exelon 
Kaj morate vedeti, preden boste uporabili zdravilo Exelon
The following additional adverse reactions have been observed with Exelon transdermal patches: delirium, pyrexia, decreased appetite, urinary incontinence (common), psychomotor hyperactivity (uncommon), erythema, urticaria, vesicles, allergic dermatitis (not known). 
Pri uporabi transdermalnih obližev Exelon so dodatno opažali še naslednje neželene učinke: delirij, zvišano telesno temperaturo, zmanjšan apetit, urinska inkontinenca (pogosto), psihomotorična hiperaktivnost (občasno), eritem, urtikarija, mehurčki, alergijski dermatitis (pogostnost neznana).
Exelon transdermal patches 9.5 mg/24 h N = 251 
Exelon transdermalni obliži 9,5 mg/24 h N = 251
In pregnant animals, rivastigmine and /or metabolites crossed the placenta. 
Pri brejih živalih so rivastigmin in/ali njegovi presnovki prehajali skozi posteljico.
What Exelon is and what it is used for What you need to know before you take Exelon How to take Exelon 
Kaj je zdravilo Exelon in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Exelon Kako jemati zdravilo Exelon Možni neželeni učinki
Patients with severe hepatic impairment have not been studied, however, Exelon oral solution may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2). 
Uporabe zdravila pri bolnikih s težko jetrno okvaro niso proučili, bolniki iz te populacije lahko kljub temu uporabljajo zdravilo Exelon peroralno raztopino, vendar jih je treba skrbno spremljati (glejte poglavji 4.4 in 5.2).
What you need to know before you take Exelon 
Kaj morate vedeti, preden boste vzeli zdravilo Exelon
What Exelon looks like and contents of the pack Exelon oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug. 
Peroralna raztopina Exelon je na voljo v obliki 50 ml ali 120 ml bistre rumene raztopine (2,0 mg/ml baze), v jantarno obarvani steklenici z za otroke varno zaporko, oblogo iz penaste gume, s kapalnim vložkom in s prilegajočim se zamaškom.
What Exelon contains - The active substance is rivastigmine. 
Kaj vsebuje zdravilo Exelon - Učinkovina je rivastigmin.
There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease. 
Zdravila Exelon ni smiselno uporabljati pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
Each Exelon 6.0 mg capsule contains 6.0 mg of rivastigmine. 
Vsaka kapsula Exelon 6,0 mg vsebuje 6,0 mg rivastigmina.
Each Exelon 1.5 mg capsule contains 1.5 mg of rivastigmine. 
Vsaka kapsula Exelon 1,5 mg vsebuje 1,5 mg rivastigmina.
You should not breast-feed during treatment with Exelon transdermal patches. 
Med zdravljenjem s transdermalnimi obliži Exelon ne smete dojiti.
What Exelon contains - The active substance is rivastigmine hydrogen tartrate. 
Kaj vsebuje zdravilo Exelon - Učinkovina je rivastigminijev hidrogentartrat.
Other side effects seen with Exelon capsules or oral solution and which may occur with the patch: 
Drugi neželeni učinki, ki so jih opažali pri uporabi kapsul ali peroralne raztopine Exelon in bi se lahko pojavili tudi pri uporabi obližev:
Transdermal patches Rivastigmine in vivo release rates per 24 h 
Odmerjanje transdermalni obliži hitrost sproščanja rivastigmina na 24 ur in vivo
The outside of the backing layer is beige and labelled with “Exelon”, “4.6 mg/24 h” and “AMCX”. 
Zunanji del krovne plasti je rjavkasto bele (beige) barve z oznakami “Exelon”, “4.6 mg/24 h” in “AMCX”.
What Exelon looks like and contents of the pack - Exelon 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on the body. 
Izgled zdravila Exelon in vsebina pakiranja - Exelon 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “EXELON 1,5 mg”.
- Exelon 4.6 mg/24 h transdermal patches: Each patch releasing 4.6 mg of rivastigmine per 24 hours is 5 cm and contains 9 mg of rivastigmine. 
- Exelon 4,6 mg/24 h transdermalni obliži: vsak obliž, ki sprosti 4,6 mg rivastigmina na 24 ur, je velik 5 cm in vsebuje 9 mg rivastigmina.
The active substance of Exelon is rivastigmine. 
Zdravilna učinkovina v zdravilu Exelon je rivastigmin.
- Exelon 9.5 mg/24 h transdermal patches: Each patch releasing 9.5 mg of rivastigmine per 24 hours is 10 cm and contains 18 mg of rivastigmine. 
- Exelon 9,5 mg/24 h transdermalni obliži: vsak obliž, ki sprosti 9,5 mg rivastigmina na 24 ur, je velik 10 cm in vsebuje 18 mg rivastigmina.
Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules rivastigmine 
Exelon 1,5 mg trde kapsule Exelon 3,0 mg trde kapsule Exelon 4,5 mg trde kapsule Exelon 6,0 mg trde kapsule rivastigmin
One of the excipients in Exelon oral solution is sodium benzoate. 
Ena od pomožnih snovi peroralne raztopine Exelon je natrijev benzoat.
Although less pronounced than with the oral formulation, exposure to rivastigmine (Cmax and AUC) increased over-proportionally by a factor of 2.6 and 4.9 when escalating from 4.6 mg/24 h to 9.5 mg/24 h and to 13.3 mg/24 h, respectively. 
Čeprav manj izrazito kot pri peroralnem odmerjanju, se je pri stopnjevanju z odmerka 4,6 mg/24 h na 9,5 mg/24 h oziroma na 13,3 mg/24 h izpostavljenost rivastigminu (Cmax in
ADAS-cog scores: A negative difference in DLSM indicates greater improvement in Exelon 15 cm as compared to Exelon 10 cm 
DLSM - razlika po metodi najmanjših kvadratov (angl. difference in least square means) LOCF - metoda prenosa zadnje ocene naprej (angl. Last Observation Carried Forward) ocene pri lestvici ADAS-cog: negativna vrednost razlike po metodi najmanjših kvadratov pomeni večje izboljšanje pri uporabi obliža Exelon 15 cm kot pri uporabi obliža Exelon 10 cm ocene pri lestvici ADCS-IADL: pozitivna vrednost razlike po metodi najmanjših kvadratov pomeni večje izboljšanje pri uporabi obliža Exelon 15 cm kot pri uporabi obliža Exelon 10 cm
Each Exelon 4.5 mg capsule contains 4.5 mg of rivastigmine. 
Vsaka kapsula Exelon 4,5 mg vsebuje 4,5 mg rivastigmina.
Exelon 13.3 mg/24 h transdermal patches: Each patch releasing 13.3 mg of rivastigmine per 24 hours is 15 cm and contains 27 mg of rivastigmine. 
- Exelon 13,3 mg/24 h transdermalni obliži: vsak obliž, ki sprosti 13,3 mg rivastigmina na 24 ur, je velik 15 cm in vsebuje 27 mg rivastigmina.
No specific interaction studies have been performed with Exelon transdermal patches. 
S transdermalnimi obliži Exelon niso izvedli specifičnih študij medsebojnega delovanja.
Each Exelon 3.0 mg capsule contains 3.0 mg of rivastigmine. 
Vsaka kapsula Exelon 3,0 mg vsebuje 3,0 mg rivastigmina.
Application site skin reactions (usually mild to moderate application site erythema), are the most frequent adverse reactions observed with the use of Exelon transdermal patch. 
Med neželenimi učinki, ki so jih opažali pri uporabi transdermalnega obliža Exelon, so najbolj pogoste kožne reakcije na mestu apliciranja (običajno blaga do zmerna rdečina kože na mestu apliciranja).
How to remove your Exelon transdermal patch 
Kako odstraniti transdermalni obliž Exelon
When and for how long to apply your Exelon transdermal patch 
Kdaj namestiti transdermalni obliž Exelon in za koliko časa
Always use Exelon transdermal patches exactly as your doctor has told you. 
Pri uporabi transdermalnih obližev Exelon natančno upoštevajte navodila zdravnika.
Exelon should not be given at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting). 
Zdravila Exelon ne smete jemati sočasno z metoklopramidom (zdravilom, ki ga uporabljamo za ublažitev ali preprečevanje navzee (slabosti s siljenjem na bruhanje) in bruhanja).
How to use Exelon 
Kako uporabljati zdravilo Exelon
The patient's weight should be monitored during therapy with Exelon transdermal patches. 
Med zdravljenjem s transdermalnimi obliži Exelon je treba spremljati bolnikovo telesno maso.
The outside of the backing layer is beige and labelled with “Exelon”, “13.3 mg/24 h” and “CNFU”. 
Zunanji del krovne plasti je rjavkasto bele (beige) barve z oznakami “Exelon”, “13.3 mg/24 h” in “CNFU”.
Where to apply your Exelon transdermal patch 
Kam namestiti transdermalni obliž Exelon
The outside of the backing layer is beige and labelled with “Exelon”, “9.5 mg/24 h” and “BHDI”. 
Zunanji del krovne plasti je rjavkasto bele (beige) barve z oznakami “Exelon”, “9.5 mg/24 h” in “BHDI”.
You should not breast-feed during treatment with Exelon. 
Med zdravljenjem z zdravilom Exelon ne smete dojiti.
Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch rivastigmine 
Exelon 4,6 mg/24 h transdermalni obliž Exelon 9,5 mg/24 h transdermalni obliž Exelon 13,3 mg/24 h transdermalni obliž rivastigmin
Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch 
Exelon 4,6 mg/24 h transdermalni obliž Exelon 9,5 mg/24 h transdermalni obliž Exelon 13,3 mg/24 h transdermalni obliž
Exelon transdermal patches 9.5 mg/24 h 
Exelon transdermalni obliži 9,5 mg/24 h
Caution when Exelon is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions). 
Previdnost je potrebna pri sočasni uporabi zdravila Exelon in katerega od antagonistov adrenergičnih receptorjev beta (učinkovin, kot je atenolol, ki ga uporabljamo za zdravljenje visokega krvnega tlaka, angine pektoris in drugih bolezni srca).
- Exelon 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “EXELON 4,5 mg” on the body. 
- Exelon 4,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo kapsule z belim napisom “EXELON 4,5 mg”.
Exelon 1.5 mg hard capsules 
Exelon 1,5 mg trde kapsule
1 transdermal patch per sachet 
1 transdermalni obliž na vrečko
Exelon 1.5 mg hard capsules rivastigmine 
Exelon 1,5 mg trde kapsule rivastigmin
- Exelon 3.0 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “EXELON 3 mg” on the body. 
- Exelon 3,0 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo kapsule z rdečim napisom “EXELON 3 mg”.
Exelon 4.5 mg hard capsules 
Exelon 4,5 mg trde kapsule
Exelon 2 mg/ml oral solution rivastigmine 
Exelon 2 mg/ml peroralna raztopina rivastigmin
Exelon 6.0 mg hard capsules 
Exelon 6,0 mg trde kapsule
Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “EXELON 4,5 mg” on body. 
Belkast do rahlo rumen prašek v kapsuli z rdečim pokrovčkom in rdečim telesom kapsule z belim napisom “EXELON 4,5 mg”.
- Exelon 6.0 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “EXELON 6 mg” on the body. 
- Exelon 6,0 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo kapsule z rdečim napisom “EXELON 6 mg”.
• Uneven heartbeat and poor control of movements Other side effects seen with Exelon transdermal patches and which may occur with the hard capsules: 
Drugi neželeni učinki, ki so jih opažali pri uporabi transdermalnih obližev Exelon in bi se lahko pojavili tudi pri uporabi trdih kapsul:
Exelon 3.0 mg hard capsules 
Exelon 3,0 mg trde kapsule
Age had no impact on the exposure to rivastigmine in Alzheimer's disease patients treated with Exelon transdermal patches. 
Pri bolnikih z Alzheimerjevo boleznijo, ki so jih zdravili s transdermalnimi obliži Exelon, starost ni vplivala na izpostavljenost rivastigminu.
Exelon 4.6 mg/24 h transdermal patch rivastigmine 
Exelon 4,6 mg/24 h transdermalni obliž rivastigmin
Exelon 4.5 mg hard capsules rivastigmine 
Exelon 4,5 mg trde kapsule rivastigmin
Exelon 9.5 mg/24 h transdermal patch rivastigmine 
Exelon 9,5 mg/24 h transdermalni obliž rivastigmin
Exelon 6.0 mg hard capsules rivastigmine 
Exelon 6,0 mg trde kapsule rivastigmin
Exelon 13.3 mg/24 h transdermal patch rivastigmine 
Exelon 13,3 mg/24 h transdermalni obliž rivastigmin
Exelon 3.0 mg hard capsules rivastigmine 
Exelon 3,0 mg trde kapsule rivastigmin
How to apply your Exelon transdermal patch 
Kako namestiti transdermalni obliž Exelon
Exelon 2 mg/ml oral solution 
Exelon 2 mg/ml peroralna raztopina
Exelon 4.6 mg/24 h transdermal patch 
Exelon 4,6 mg/24 h transdermalni obliž
42 transdermal patches (sachet: paper/PET/PE/alu/PA) 
42 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on body. 
Belkast do rahlo rumen prašek v kapsuli z rumenim pokrovčkom in rumenim telesom kapsule z rdečim napisom “EXELON 1,5 mg”.
Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “EXELON 6 mg” on body. 
Belkast do rahlo rumen prašek v kapsuli z rdečim pokrovčkom in oranžnim telesom kapsule z rdečim napisom “EXELON 6 mg”.
Exelon might interfere with anticholinergic medicines some of which are medicines used to relieve stomach cramps or spasms (e.g. dicyclomine), to treat Parkinson's disease (e.g. amantadine) or to prevent motion sickness (e.g. diphenhydramine, scopolamine, or meclizine). 
ki se uporabljajo za lajšanje želodčnih krčev (npr. diciklomin), za zdravljenje Parkinsonove bolezni (npr. amantadin) ali za preprečevanje potovalne slabosti (npr. difenhidramin, skopolamin ali meklizin) oziroma ta zdravila lahko vplivajo na rivastigmin.
Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “EXELON 3 mg” on body. 
Belkast do rahlo rumen prašek v kapsuli z oranžnim pokrovčkom in oranžnim telesom kapsule z rdečim napisom “EXELON 3 mg”.
How to take Exelon 
Kako jemati zdravilo Exelon
42 transdermal patches (sachet: paper/PET/alu/PAN) 
42 transdermalnih obližev (vrečka: papir/PET/alu/PAN)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING 
Izgled zdravila Exelon in vsebina pakiranja
Exelon 13.3 mg/24 h transdermal patch 
Exelon 13,3 mg/24 h transdermalni obliž
Exelon 9.5 mg/24 h transdermal patch 
Exelon 9,5 mg/24 h transdermalni obliž
No study was conducted with Exelon transdermal patches in subjects with hepatic impairment. 
Pri osebah z okvaro jeter niso opravili nobene študije s transdermalnimi obliži Exelon.
7 transdermal patches (sachet: paper/PET/PE/alu/PA) 
7 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
84 transdermal patches (sachet: paper/PET/PE/alu/PA) 
84 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
60 transdermal patches (sachet: paper/PET/PE/alu/PA) 
60 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
- if you have a skin reaction spreading beyond the patch size, if there is a more intense local reaction (such as blisters, increasing skin inflammation, swelling) and if it does not improve within 48 hours after removal of the transdermal patch. 
Ne jemljite zdravila Exelon - če ste alergični na rivastigmin (zdravilno učinkovino v zdravilu Exelon) ali katero koli sestavino tega zdravila (navedeno v poglavju 6); - če opazite kožno reakcijo, ki se širi preko površine, ki jo pokriva transdermalni obliž, če je reakcija na tem mestu močneje izražena (če se pojavijo mehurčki, če je vnetje oziroma oteklina vse bolj izrazita) in če se ti znaki v 48 urah po odstranitvi transdermalnega obliža ne izboljšajo.
90 transdermal patches (sachet: paper/PET/PE/alu/PA) 
90 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
30 transdermal patches (sachet: paper/PET/PE/alu/PA) 
30 transdermalnih obližev (vrečka: papir/PET/PE/alu/PA)
No study was conducted with Exelon transdermal patches in subjects with renal impairment. 
Pri osebah z okvaro ledvic niso opravili nobene študije s transdermalnimi obliži Exelon.